Wed
11/14
2007
ÅüǢɤÈÅü¼Á¤È±¿Æ°
¤ª¤Ï¤è¤¦¤´¤¶¤¤¤Þ¤¹¡£
º£Æü¤Ï¼ã¼Ô£²·¿ÅüÇ¢¿Í¤µ¤ó¤«¤é¡¢¼ÁÌ䡦¥³¥á¥ó¥Èĺ¤¤Þ¤·¤¿¤Î¤Ç¤ªÅú¤¨Ãפ·¤Þ¤¹¡£Â¾¤Î¥Ö¥í¥°ÆÉ¼Ô¤Î³§¤µ¤ó¤Ë¤â¶½Ì£¤Î¤¢¤ëÆâÍÆ¤À¤È»×¤¤¤Þ¤¹¡£
¡Ö¹¾ÉôÀèÀ¸¡¡¤Ï¤¸¤á¤Þ¤·¤Æ¡£¶ËºÇ¶áÀèÀ¸¤Î¥Ö¥í¥°¤Î¸ºß¤òÃΤꡢ·ìÅüÃͤò°ÂÄꤵ¤»¤ë»ö¤¬½ÐÍè¤ëÍͤˤʤäơ¡´î¤ó¤ÇËèÆü¤ò²á¤´¤·¤Æ¤ª¤ê¤Þ¤¹¼ã¼Ô£²·¿ÅüÇ¢¿Í¤Ç¤¹¡£
¾¡¼êÆã £³¤ÄÄø ¼ÁÌ䤵¤»¤ÆÌã¤Ã¤Æ¤âµ¹¤·¤¤¤Ç¤·¤ç¤¦¤«¡©
»ä¤Ïȯ¾É½é´ü ¥¤¥ó¥·¥å¥ê¥óÄñ¹³À¤¬´°¼£¤·¤Æ¤¤¤Ê¤¤¾õ¶·¤Î°Ù¡¢¥Ö¥É¥¦Åü¥¹¥Ñ¥¤¥¯¤¬µ¯¤³¤ê¤ä¤¹¤¤¾õ¶·¤Ë¤¢¤ë¤È»×¤Ã¤Æ¤¤¤Þ¤¹¡£(ȯ¾É¸å¤Î·Ð²á»þ´Ö¤Ï¤¢¤Þ¤ê´Ø·¸¤Ê¤¤¤Î¤«¤âÃΤì¤Þ¤»¤ó¤¬)
¤½¤³¤ÇÅü¼Á¤ò¸Â¤ê¤Ê¤¯Â¿¤¯¼è¤é¤Ê¤¤¿©»öÎÅË¡¤¬¥Ù¥¹¥È¤À¤È¤Ï»×¤¤¤Þ¤¹¤¬¡¢¤½¤Î¼ÂÁ©¤¬Æñ¤·¤¤´Ä¶¤Î¾ì¹ç¡¢¤Ä¤Þ¤ê¤É¤¦¤·¤Æ¤âÅü¼Á¤¬Â¿¤¯´Þ¤Þ¤ì¤ë¿©»ö¤ò¼è¤ë»ö¤¬Èò¤±¤é¤ì¤Ê¤¤¾ì¹ç¡¢¿©¸å¤Î±¿Æ°¤Ç·ìÅüÃͤò²¼¤²¤Æ¤¤¤¯É¬Í×À¤¬¤¢¤ë¤È»×¤¤¡¢¤½¤ì¤ò¼ÂÁ©¤·¡¢¸½ºßÀµ¾ïÃͤòÊݤäƤޤ¹¤¬¡¢
¡ º£¸åĹ´ü¤ËÏˤꡡ¡Ö¿Åü¼Á¿©»ö¡Ü¿©¸å±¿Æ°¡×¡¡¤Ç·ìÅüÃͤò¥³¥ó¥È¥í¡¼¥ë¤·Â³¤±¤ÆÎɤ¤¤â¤Î¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©
¿´ÇÛ»ö¤Ï¡¢¿©¸å¤Î±¿Æ°¤Î»þ´ÖÂÓ¤ò¶ËÎÏ£±¡Á1.5»þ´Ö¸å°ÊÆâ¤Ë³«»Ï¤¹¤ëÍÍ¡¡¿´³Ý¤±¤Æ¤Þ¤¹¤¬¡¢¿©¤Ù¤¿ÆâÍÆ¤Ë¤è¤Ã¤Æ¤Ï·ìÅüÃͤÎÊÑÆ°¤Î»ÅÊý¤¬»þ´ÖÂӤˤè¤Ã¤ÆÊѤï¤Ã¤Æ¤¤Þ¤¹¤·¡¢±¿Æ°¤ò¤· ·ë²ÌŪ¤Ë¿ôÃͤϲ¼¤¬¤Ã¤ÆÍè¤ë¤È¤Ï±¾¤¨¡¢¾¯¤Ê¤«¤é¤º°ìÄê¤Î»þ´Ö200 over¤È¤Ê¤Ã¤Æ¤¤¤ë²ÄǽÀ¤¬¹Í¤¨¤é¤ì¤Þ¤¹¡£
½Ö´ÖŪ¤Ë·ìÅüÃͤ¬¹â¤¤¤Î¤â¤ä¤Ï¤êÌäÂê¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©
¢ ¤É¤¦¤·¤Æ¤â¿©¸å¤Î±¿Æ°¤¬½ÐÍè¤Ê¤¤¥±¡¼¥¹¤â½µ¤Ë£²,£³²óÄøÅÙ¤¢¤í¤¦¤«¤È»×¤¤¤Þ¤¹¡£
ÃæÄ¹´üŪ¤Ë¸«¤¿¾ì¹ç ¹¥¤Þ¤·¤¯¤Ê¤¤¤Î¤Ïʬ¤«¤ê¤Þ¤¹¤¬¡¢¹çÊ»¾É¤òµ¯¤³¤µ¤Ê¤¤°Ù¤Ë¤Ï¤É¤ÎÄøÅ٤Ǥ¢¤ì¤ÐÌäÂê¤Ê¤¤¤â¤Î¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©¡¡
º£¸åHbA1C¿ôÃÍÊÑÆ°¤¬¤¦¤Þ¤¯¤¤¤¯¥ì¥Ù¥ë¤Ç¤¢¤ì¤Ð½½Ê¬¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©¡Êɾ²Á¤Ë»þ´Ö¤¬¤«¤«¤ê¤Þ¤¹¤¬.....¡Ë
»²¹Í¤Þ¤Ç¤Ë¡¢¿©Á° 85 ¢ª¡¡¿©¸å (¿äÄꥫ¡¼¥ÜÎÌ 75g)+ ±¿Æ° (30min.walking) ¤Ç 125¡Á135 ¤Î·ìÅüÃÍÊÑÆ°¤È¤¤¤¦¿©À¸³è¤¬Â¿¤¤¤Ç¤¹¡£
*º£¤Ï¥«¡¼¥ÜÎ̤ò 60g/¿© °ÊÆâ ¤Ë¶ËÎÏÍÞ¤¨¤ëÍÍ¡¡ÅØÎϤϤ·¤Æ¤Þ¤¹¤¬¡¢Ã桹Æñ¤·¤¤¿©´Ä¶¤Ë¤¤¤Þ¤¹¡£
£ °ìöÅüÇ¢¿Í¤Ë¤Ê¤Ã¤Æ¤·¤Þ¤Ã¤¿¾ì¹ç¡¢Âç¾®¥Ö¥É¥¦Åü¥¹¥Ñ¥¤¥¯¤Ïµ¯¤³¤ê³¤±¤ë¤â¤Î¤È¹Í¤¨¤ë¤Ù¤¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©
¡¡¡Ê·ò¹¯¿Í¤Î¥¹¥Ñ¥¤¥¯¥ì¥Ù¥ë¤Ë¶á¤Å¤±¤ë²ÄǽÀ¤Ï¤Ê¤¤¤â¤Î¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©¡Ë
¾¤ÎÊý¤Î¥Ö¥í¥°¤Ç¡¢´°¼£¤òÌܻؤ·¤Æ¤ª¤é¤ì¤ëÊý¤¬¤¤¤é¤Ã¤·¤ã¤Ã¤Æ¡¢½ÐÍè¤ì¤Ð»ä¤â´èÄ¥¤Ã¤Æ¤ß¤¿¤¤¤â¤Î¤Ç¤¹¤¬¡¢°å³ØÅª¤Ë¤ä¤Ï¤ê´°¼£¤Ï¸½¼ÂŪ¤Ç¤Ï¤Ê¤¤¤Î¤Ç¤·¤ç¤¦¤«¡©
ÃÙ¤¯¤Ê¤ê¤Þ¤·¤¿¤¬¡¢¼«¸Ê¾Ò²ð¤ò¡£»ä¤Ïº£Ç¯£¸·îËö¤Ë¿©¸å£²»þ´Ö·ìÅüÃÍ452,HbA1C 11.2%¤Ç¨¶ÛµÞÆþ±¡¤·¡¢£²½µ´Ö¤ÇHbA1C 10.2% ·ìÅüÃͤϿ©Á°100°Ê²¼, ¿©¸å(+±¿Æ°)140°Ê²¼¤È¤Ê¤êÂౡ¤·¤Þ¤·¤¿¡£10·îƬ¤Ë¤ÏHbA1C 9.2% ¤Ç¸½ºß¤Ë»ê¤ê ¤½¤Î¸å³¤³°¶Ð̳¤ÇǯËö¤Ë¸¡ººÍ½Äê¤Ç¤¹¡£
BMI=20.3¤Ç¦ÃGTP¾¿ôÃͤÏÀµ¾ïÃͤǤ¹¤¬¡¢¿¿¤ÃÇò¤±¤Ã¤±¤Î»éËôΤǤ·¤¿¡Ê¾Ð¡Ë [¤³¤ì¤¬¥¤¥ó¥·¥å¥ê¥ó¤Ë°µº¤ò¤·¤Æ¤¤¤ë²ÄǽÀÂç¤Ç¤¹¤¬....]
Àè·î¤Þ¤Ç¤Ï¥«¥í¥ê¡¼À©¸Â¤Ð¤«¤ê¤ò¸À¤ï¤ì¤ÆÃ桹¿©Á°·ìÅüÃͤò¥³¥ó¥È¥í¡¼¥ë½ÐÍ褺¶³¦¤ÎÈϰϤò¤¦¤í¤Ä¤¤¤Æ¤Þ¤·¤¿¤¬¡¢ÀèÀ¸¤Î¥Ö¥í¥°¤Ë½Ð²ñ¤¤¡¢¥«¡¼¥ÜÎ̤òÀ©¸Â¤·¤Ê¤¬¤éº£¡¡¿©Á°100°Ê²¼ ¿©¸å¡Ê+±¿Æ°) 120¡Á135 ¤Ç¥³¥ó¥È¥í¡¼¥ë¤·¤Æ¤ª¤ê¤Þ¤¹¡£°ø¤ß¤ËÌô¤Ï°ìÀÚ°û¤ó¤Ç¤Þ¤»¤ó¡£ÀèÀ¸¤¬À֥磻¥ó¤È¥Ê¥Ã¥Ä¤Çenjoy¤µ¤ì¤Æ¤¤¤ë¤ÈÃΤꡢ»ä¤â¤³¤³£±½µ´ÖËþµÊ¤·¤¿À¸³è¤òÁ÷¤ì¤ëÍͤˤʤê¤Þ¤·¤¿¡£ËÜÅöÁÇÀ²¤é¤·¤¤¤Ç¤¹¡£´¶¼Õ¤Î°ÕÌ£¤â´Þ¤á¤ÆÆüËܤ˵¢¤Ã¤¿¤é¨ËܤòÇã¤Ã¤Æ¡¢±ÉÍܻΤοͤ˴«¤á¤Æ¤ß¤è¤¦¤È»×¤Ã¤Æ¤Þ¤¹¡£¡¡
¿©¸å£²»þ´Ö¤Î½ÅÍ×À¤ò»ä¤ÎôÅö°å¤ØÁêÃ̤·¤¿»ö¤¬¤¢¤ê¡¢¤½¤Î»þ¤Ï¶²¤é¤¯È¯¾É½é´ü¤Ç¤¢¤ë¤¿¤á¤« ¼è¤ê´º¤¨¤ºµ¯¾²»þ¤Î¤ß¬Äꤹ¤ëÍͤ˻ؼ¨¤ò¼õ¤±¤Æ¤Þ¤¹¤¬¡¢¸Ä¿ÍŪ¤Ë¹¾ÉôÀèÀ¸¤Î°Õ¸«¤Ë²ÄÌ鯱°Õ¤·¤Æ¤ª¤ê¡¢ÅÔÅÙ¬Äꤷ¤¿¤¤¤Î¤Ç¤¹¤¬¡¢»ÄǰÆã »ý¤Ã¤Æ¤¤¤ë¥Á¥Ã¥×¿ô¤¬Â¤é¤Ê¤¯¤Ê¤ë¤Î¤Ç¤¢¤Þ¤ê¬Äê½ÐÍè¤Þ¤»¤ó¡£
ǯÎ𣳣°Âå¤È¤¤¤¦»ö¤â¤¢¤ê¡¢À§ÈóÀèÀ¸¤Î°Õ¸«¤òĺÂפ·¤Æ¡¢¤³¤ì¤«¤é¤ÎŤ¤ÅüÇ¢À¸³è¤ò¾¯¤·¤Ç¤â·ò¹¯¿Í¤Ë¶á¤¤·Á¤Ç²á¤´¤»¤¿¤é¡¡¤È»×¤Ã¤Æ¤ª¤ê¤Þ¤¹¤Î¤Ç¡¢À§È󶦵¹¤·¤¯¤ª´ê¤¤Ãפ·¤Þ¤¹¡£
¼ã¼Ô£²·¿ÅüÇ¢¿Í | 2007.11.11(Æü) 23:51 | URL | ¡×
¼ã¼Ô£²·¿ÅüÇ¢¿Í¤µ¤ó¡£¥³¥á¥ó¥È¡¦¼ÁÌ䤢¤ê¤¬¤È¤¦¤´¤¶¤¤¤Þ¤¹¡£
¤Þ¤¿ ¡Ö¥«¥í¥ê¡¼À©¸Â¢ªÅü¼ÁÀ©¸Â¡×¤Ç¡¢ÁáÄ«¶õÊ¢»þ·ìÅüÃͤ¬£±£°£°£í£ç°Ê²¼¤È¥³¥ó¥È¥í¡¼¥ëÎɹ¥¤Ë¤Ê¤Ã¤¿¤È¤Î¤³¤È¡¢¤ª¤á¤Ç¤È¤¦¤´¤¶¤¤¤Þ¤¹¡£
¹¬¤¤·Ð¸ý·ìÅü¹ß²¼Ìô¤Ê¤ÉÆâÉþ¤·¤Æ¤ª¤é¤ì¤Þ¤»¤ó¤Î¤Ç¡¢°ÂÁ´¤ËÅü¼ÁÀ©¸Â¿©¤¬¼ÂÁ©¤Ç¤¤Þ¤¹¡£
¡Ö¡ º£¸åĹ´ü¤ËÏˤꡡ¡Ö¿Åü¼Á¿©»ö¡Ü¿©¸å±¿Æ°¡×¡¡¤Ç·ìÅüÃͤò¥³¥ó¥È¥í¡¼¥ë¤·Â³¤±¤ÆÎɤ¤¤â¤Î¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©
¿´ÇÛ»ö¤Ï¡¢¿©¸å¤Î±¿Æ°¤Î»þ´ÖÂÓ¤ò¶ËÎÏ£±¡Á1.5»þ´Ö¸å°ÊÆâ¤Ë³«»Ï¤¹¤ëÍÍ¡¡¿´³Ý¤±¤Æ¤Þ¤¹¤¬¡¢¿©¤Ù¤¿ÆâÍÆ¤Ë¤è¤Ã¤Æ¤Ï·ìÅüÃͤÎÊÑÆ°¤Î»ÅÊý¤¬»þ´ÖÂӤˤè¤Ã¤ÆÊѤï¤Ã¤Æ¤¤Þ¤¹¤·¡¢±¿Æ°¤ò¤· ·ë²ÌŪ¤Ë¿ôÃͤϲ¼¤¬¤Ã¤ÆÍè¤ë¤È¤Ï±¾¤¨¡¢¾¯¤Ê¤«¤é¤º°ìÄê¤Î»þ´Ö200 over¤È¤Ê¤Ã¤Æ¤¤¤ë²ÄǽÀ¤¬¹Í¤¨¤é¤ì¤Þ¤¹¡£
½Ö´ÖŪ¤Ë·ìÅüÃͤ¬¹â¤¤¤Î¤â¤ä¤Ï¤êÌäÂê¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©¡×
¡ã¿Åü¼Á¿©»ö¡Ü¿©¸å±¿Æ°¡ä¤Ç·ìÅüÃͤò¥³¥ó¥È¥í¡¼¥ë¤ò¤·Â³¤±¤Æ¤â£Ï£Ë¤Ç¤¹¡£
¥â¥Ç¥ë¤È¤·¤Æ¥Ô¥Þ¥¤¥ó¥Ç¥£¥¢¥ó¤¬¤¤¤Þ¤¹¡£Êƹñ¤Îµï½»¶è¤Ç¤¯¤é¤·¤Æ¤¤¤ë¥Ô¥Þ¥¤¥ó¥Ç¥£¥¢¥ó¤Ï¡ã¹âÅü¼Á¿©¡Ü±¿Æ°ÉÔ¡ä¤Ç¿Í¸ý¤Î£µ³ä¤¬ÅüǢɤǤ¹¡£
°ìÊý¡¢¥á¥¥·¥³¤Î¥Ô¥Þ¥¤¥ó¥Ç¥£¥¢¥ó¤Ï¡ã¹âÅü¼Á¿©¡Ü±¿Æ°¤¿¤Ã¤×¤ê¡ä¤ÇÅüǢɤϤۤȤó¤É¤¤¤Þ¤»¤ó¡£¡Ê£¹¡¥£²£·¡¢£²£¸¤Î¥Ö¥í¥°»²¾È¤·¤Æ¤¯¤À¤µ¤¤¤Í¡Ë
¤½¤ì¤«¤é¿©¸å·ìÅüÃÍ£±£¸£°£í£ç¡¿£ä£ì̤Ëþ¤¬ÌÜɸ¤Ç¤¹¡£¤³¤Î¿ôÃͤʤ顢·ì´É¤Î¹çÊ»¾É¤¬¤Û¤È¤ó¤ÉÀ¸¤¸¤Ê¤¤¤È¤µ¤ì¤Æ¤¤¤Þ¤¹¡£¡Ê¡ö¡öKumamoto Study¡¡·§ËÜÂç³Ø¡¡¡Ë
£±£¸£°£í£ç¡¿£ä£ì¤òͤ¨¤ë¹â·ìÅü¤¬»ý³¤¹¤ë¤Û¤É·ì´É¤Ë¤ÏÎɤ¯¤Ê¤¤¤Ç¤·¤ç¤¦¡£
¡Ö¢ ¤É¤¦¤·¤Æ¤â¿©¸å¤Î±¿Æ°¤¬½ÐÍè¤Ê¤¤¥±¡¼¥¹¤â½µ¤Ë£²,£³²óÄøÅÙ¤¢¤í¤¦¤«¤È»×¤¤¤Þ¤¹¡£
ÃæÄ¹´üŪ¤Ë¸«¤¿¾ì¹ç ¹¥¤Þ¤·¤¯¤Ê¤¤¤Î¤Ïʬ¤«¤ê¤Þ¤¹¤¬¡¢¹çÊ»¾É¤òµ¯¤³¤µ¤Ê¤¤°Ù¤Ë¤Ï¤É¤ÎÄøÅ٤Ǥ¢¤ì¤ÐÌäÂê¤Ê¤¤¤â¤Î¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©¡×
Kumamoto Study¤Ë¤è¤ì¤Ð¡¢¡ãHbA1c£¶¡¥£µ¡ó̤Ëþ¡¢¶õÊ¢»þ·ìÅüÃÍ£±£±£°£í£ç̤Ëþ¡¢¿©¸å·ìÅüÃÍ£±£¸£°£í£ç¡¿£ä£ì̤Ëþ¡ä¤Ê¤é¤Ð¹çÊ»¾É¤Î¿ÊŸ¤¬Á˻ߤǤ¤ë¤½¤¦¤Ç¤¹¡£
¡Ö£ °ìöÅüÇ¢¿Í¤Ë¤Ê¤Ã¤Æ¤·¤Þ¤Ã¤¿¾ì¹ç¡¢Âç¾®¥Ö¥É¥¦Åü¥¹¥Ñ¥¤¥¯¤Ïµ¯¤³¤ê³¤±¤ë¤â¤Î¤È¹Í¤¨¤ë¤Ù¤¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©¡Ê·ò¹¯¿Í¤Î¥¹¥Ñ¥¤¥¯¥ì¥Ù¥ë¤Ë¶á¤Å¤±¤ë²ÄǽÀ¤Ï¤Ê¤¤¤â¤Î¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©¡Ë
¾¤ÎÊý¤Î¥Ö¥í¥°¤Ç¡¢´°¼£¤òÌܻؤ·¤Æ¤ª¤é¤ì¤ëÊý¤¬¤¤¤é¤Ã¤·¤ã¤Ã¤Æ¡¢½ÐÍè¤ì¤Ð»ä¤â´èÄ¥¤Ã¤Æ¤ß¤¿¤¤¤â¤Î¤Ç¤¹¤¬¡¢°å³ØÅª¤Ë¤ä¤Ï¤ê´°¼£¤Ï¸½¼ÂŪ¤Ç¤Ï¤Ê¤¤¤Î¤Ç¤·¤ç¤¦¤«¡©¡×
ÅüǢɤȿÇÃǤµ¤ì¤¿»þÅÀ¤Ç¡¢ç¹Â¡¤Î¦ÂºÙ˦¤Î£±¡Á£²³ä¤¬²óÉüÉÔǽ¤Î¥À¥á¡¼¥¸¤ò¼õ¤±¤Æ¤¤¤ë¤³¤È¤¬Â¿¤¤¤Ç¤¹¡£¤µ¤é¤Ë£²¡Á£³³ä¤ÎºÙ˦¤â¼å¤Ã¤Æ¤¤¤ë²ÄǽÀ¤¬¤¢¤ê¤Þ¤¹¡£
³°Éô¤«¤é¥¤¥ó¥¹¥ê¥óÃí¼Í¤òÂǤġ¢°¿¤¤¤Ï Åü¼ÁÀ©¸Â¿©¤Î¼ÂÁ©¤Ë¤è¤ê¡¢ç¹Â¡¤Î¦ÂºÙ˦¤¬µÙÍܤǤ¤Æ²óÉü¤¹¤ë¤³¤È¤Ï¤¢¤ê¤Þ¤¹¡£¡Ê£±£±¡¥£¹¥Ö¥í¥°»²¾È¤·¤Æ¤¯¤À¤µ¤¤¡Ë
½¾¤Ã¤Æ¡¢·ò¹¯¿Í¤Î¥ì¥Ù¥ë¤Ë¾¯¤·¶á¤Å¤¯¤³¤È¤Ï²Äǽ¤Ç¤¹¤¬¡¢´°Á´²óÉü¤Ï¤¢¤ê¤Þ¤»¤ó¡£
»ä¤â Åü¼ÁÀ©¸Â¿©¤ò³¤±¤ë¸Â¤ê¤Ï·ìÅü¥Ç¡¼¥¿¤ÏÀµ¾ï¿Í¤Ç¤¹¤¬¡¢Åü¼Á¤òÀݼ褹¤ì¤Ð¡¢Î㤨GI¤ÎÄ㤤¸¼ÊƤǤ⣲£°£°£í£ç¤òͤ¨¤Þ¤¹¡£
Îã³°¤È¤·¤Æ¡¢¥¤¥ó¥¹¥ê¥óʬÈçǽÎϤÏÊݤ¿¤ì¤Æ¤¤¤Æ¡¢¥¤¥ó¥¹¥ê¥óÄñ¹³À¤¬¼ç¡ÊÎ㤨¤ÐÈîËþ¤Î¤¿¤á¡Ë¤ÎÅüÇ¢¿Í¤Ï¡¢ÈîËþ¤¬²þÁ±¤¹¤ë¤³¤È¤ÇÀµ¾ï¿Í¤ËÌá¤ë¤³¤È¤Ï¤¢¤êÆÀ¤Þ¤¹¡£
¡ö¡öKumamoto Study
Shichiri M, Kishikawa H, Ohkubo Y, Wake N: Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23 Suppl 2:B21-29, 2000
¹¾Éô¹¯Æó
º£Æü¤Ï¼ã¼Ô£²·¿ÅüÇ¢¿Í¤µ¤ó¤«¤é¡¢¼ÁÌ䡦¥³¥á¥ó¥Èĺ¤¤Þ¤·¤¿¤Î¤Ç¤ªÅú¤¨Ãפ·¤Þ¤¹¡£Â¾¤Î¥Ö¥í¥°ÆÉ¼Ô¤Î³§¤µ¤ó¤Ë¤â¶½Ì£¤Î¤¢¤ëÆâÍÆ¤À¤È»×¤¤¤Þ¤¹¡£
¡Ö¹¾ÉôÀèÀ¸¡¡¤Ï¤¸¤á¤Þ¤·¤Æ¡£¶ËºÇ¶áÀèÀ¸¤Î¥Ö¥í¥°¤Î¸ºß¤òÃΤꡢ·ìÅüÃͤò°ÂÄꤵ¤»¤ë»ö¤¬½ÐÍè¤ëÍͤˤʤäơ¡´î¤ó¤ÇËèÆü¤ò²á¤´¤·¤Æ¤ª¤ê¤Þ¤¹¼ã¼Ô£²·¿ÅüÇ¢¿Í¤Ç¤¹¡£
¾¡¼êÆã £³¤ÄÄø ¼ÁÌ䤵¤»¤ÆÌã¤Ã¤Æ¤âµ¹¤·¤¤¤Ç¤·¤ç¤¦¤«¡©
»ä¤Ïȯ¾É½é´ü ¥¤¥ó¥·¥å¥ê¥óÄñ¹³À¤¬´°¼£¤·¤Æ¤¤¤Ê¤¤¾õ¶·¤Î°Ù¡¢¥Ö¥É¥¦Åü¥¹¥Ñ¥¤¥¯¤¬µ¯¤³¤ê¤ä¤¹¤¤¾õ¶·¤Ë¤¢¤ë¤È»×¤Ã¤Æ¤¤¤Þ¤¹¡£(ȯ¾É¸å¤Î·Ð²á»þ´Ö¤Ï¤¢¤Þ¤ê´Ø·¸¤Ê¤¤¤Î¤«¤âÃΤì¤Þ¤»¤ó¤¬)
¤½¤³¤ÇÅü¼Á¤ò¸Â¤ê¤Ê¤¯Â¿¤¯¼è¤é¤Ê¤¤¿©»öÎÅË¡¤¬¥Ù¥¹¥È¤À¤È¤Ï»×¤¤¤Þ¤¹¤¬¡¢¤½¤Î¼ÂÁ©¤¬Æñ¤·¤¤´Ä¶¤Î¾ì¹ç¡¢¤Ä¤Þ¤ê¤É¤¦¤·¤Æ¤âÅü¼Á¤¬Â¿¤¯´Þ¤Þ¤ì¤ë¿©»ö¤ò¼è¤ë»ö¤¬Èò¤±¤é¤ì¤Ê¤¤¾ì¹ç¡¢¿©¸å¤Î±¿Æ°¤Ç·ìÅüÃͤò²¼¤²¤Æ¤¤¤¯É¬Í×À¤¬¤¢¤ë¤È»×¤¤¡¢¤½¤ì¤ò¼ÂÁ©¤·¡¢¸½ºßÀµ¾ïÃͤòÊݤäƤޤ¹¤¬¡¢
¡ º£¸åĹ´ü¤ËÏˤꡡ¡Ö¿Åü¼Á¿©»ö¡Ü¿©¸å±¿Æ°¡×¡¡¤Ç·ìÅüÃͤò¥³¥ó¥È¥í¡¼¥ë¤·Â³¤±¤ÆÎɤ¤¤â¤Î¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©
¿´ÇÛ»ö¤Ï¡¢¿©¸å¤Î±¿Æ°¤Î»þ´ÖÂÓ¤ò¶ËÎÏ£±¡Á1.5»þ´Ö¸å°ÊÆâ¤Ë³«»Ï¤¹¤ëÍÍ¡¡¿´³Ý¤±¤Æ¤Þ¤¹¤¬¡¢¿©¤Ù¤¿ÆâÍÆ¤Ë¤è¤Ã¤Æ¤Ï·ìÅüÃͤÎÊÑÆ°¤Î»ÅÊý¤¬»þ´ÖÂӤˤè¤Ã¤ÆÊѤï¤Ã¤Æ¤¤Þ¤¹¤·¡¢±¿Æ°¤ò¤· ·ë²ÌŪ¤Ë¿ôÃͤϲ¼¤¬¤Ã¤ÆÍè¤ë¤È¤Ï±¾¤¨¡¢¾¯¤Ê¤«¤é¤º°ìÄê¤Î»þ´Ö200 over¤È¤Ê¤Ã¤Æ¤¤¤ë²ÄǽÀ¤¬¹Í¤¨¤é¤ì¤Þ¤¹¡£
½Ö´ÖŪ¤Ë·ìÅüÃͤ¬¹â¤¤¤Î¤â¤ä¤Ï¤êÌäÂê¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©
¢ ¤É¤¦¤·¤Æ¤â¿©¸å¤Î±¿Æ°¤¬½ÐÍè¤Ê¤¤¥±¡¼¥¹¤â½µ¤Ë£²,£³²óÄøÅÙ¤¢¤í¤¦¤«¤È»×¤¤¤Þ¤¹¡£
ÃæÄ¹´üŪ¤Ë¸«¤¿¾ì¹ç ¹¥¤Þ¤·¤¯¤Ê¤¤¤Î¤Ïʬ¤«¤ê¤Þ¤¹¤¬¡¢¹çÊ»¾É¤òµ¯¤³¤µ¤Ê¤¤°Ù¤Ë¤Ï¤É¤ÎÄøÅ٤Ǥ¢¤ì¤ÐÌäÂê¤Ê¤¤¤â¤Î¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©¡¡
º£¸åHbA1C¿ôÃÍÊÑÆ°¤¬¤¦¤Þ¤¯¤¤¤¯¥ì¥Ù¥ë¤Ç¤¢¤ì¤Ð½½Ê¬¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©¡Êɾ²Á¤Ë»þ´Ö¤¬¤«¤«¤ê¤Þ¤¹¤¬.....¡Ë
»²¹Í¤Þ¤Ç¤Ë¡¢¿©Á° 85 ¢ª¡¡¿©¸å (¿äÄꥫ¡¼¥ÜÎÌ 75g)+ ±¿Æ° (30min.walking) ¤Ç 125¡Á135 ¤Î·ìÅüÃÍÊÑÆ°¤È¤¤¤¦¿©À¸³è¤¬Â¿¤¤¤Ç¤¹¡£
*º£¤Ï¥«¡¼¥ÜÎ̤ò 60g/¿© °ÊÆâ ¤Ë¶ËÎÏÍÞ¤¨¤ëÍÍ¡¡ÅØÎϤϤ·¤Æ¤Þ¤¹¤¬¡¢Ã桹Æñ¤·¤¤¿©´Ä¶¤Ë¤¤¤Þ¤¹¡£
£ °ìöÅüÇ¢¿Í¤Ë¤Ê¤Ã¤Æ¤·¤Þ¤Ã¤¿¾ì¹ç¡¢Âç¾®¥Ö¥É¥¦Åü¥¹¥Ñ¥¤¥¯¤Ïµ¯¤³¤ê³¤±¤ë¤â¤Î¤È¹Í¤¨¤ë¤Ù¤¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©
¡¡¡Ê·ò¹¯¿Í¤Î¥¹¥Ñ¥¤¥¯¥ì¥Ù¥ë¤Ë¶á¤Å¤±¤ë²ÄǽÀ¤Ï¤Ê¤¤¤â¤Î¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©¡Ë
¾¤ÎÊý¤Î¥Ö¥í¥°¤Ç¡¢´°¼£¤òÌܻؤ·¤Æ¤ª¤é¤ì¤ëÊý¤¬¤¤¤é¤Ã¤·¤ã¤Ã¤Æ¡¢½ÐÍè¤ì¤Ð»ä¤â´èÄ¥¤Ã¤Æ¤ß¤¿¤¤¤â¤Î¤Ç¤¹¤¬¡¢°å³ØÅª¤Ë¤ä¤Ï¤ê´°¼£¤Ï¸½¼ÂŪ¤Ç¤Ï¤Ê¤¤¤Î¤Ç¤·¤ç¤¦¤«¡©
ÃÙ¤¯¤Ê¤ê¤Þ¤·¤¿¤¬¡¢¼«¸Ê¾Ò²ð¤ò¡£»ä¤Ïº£Ç¯£¸·îËö¤Ë¿©¸å£²»þ´Ö·ìÅüÃÍ452,HbA1C 11.2%¤Ç¨¶ÛµÞÆþ±¡¤·¡¢£²½µ´Ö¤ÇHbA1C 10.2% ·ìÅüÃͤϿ©Á°100°Ê²¼, ¿©¸å(+±¿Æ°)140°Ê²¼¤È¤Ê¤êÂౡ¤·¤Þ¤·¤¿¡£10·îƬ¤Ë¤ÏHbA1C 9.2% ¤Ç¸½ºß¤Ë»ê¤ê ¤½¤Î¸å³¤³°¶Ð̳¤ÇǯËö¤Ë¸¡ººÍ½Äê¤Ç¤¹¡£
BMI=20.3¤Ç¦ÃGTP¾¿ôÃͤÏÀµ¾ïÃͤǤ¹¤¬¡¢¿¿¤ÃÇò¤±¤Ã¤±¤Î»éËôΤǤ·¤¿¡Ê¾Ð¡Ë [¤³¤ì¤¬¥¤¥ó¥·¥å¥ê¥ó¤Ë°µº¤ò¤·¤Æ¤¤¤ë²ÄǽÀÂç¤Ç¤¹¤¬....]
Àè·î¤Þ¤Ç¤Ï¥«¥í¥ê¡¼À©¸Â¤Ð¤«¤ê¤ò¸À¤ï¤ì¤ÆÃ桹¿©Á°·ìÅüÃͤò¥³¥ó¥È¥í¡¼¥ë½ÐÍ褺¶³¦¤ÎÈϰϤò¤¦¤í¤Ä¤¤¤Æ¤Þ¤·¤¿¤¬¡¢ÀèÀ¸¤Î¥Ö¥í¥°¤Ë½Ð²ñ¤¤¡¢¥«¡¼¥ÜÎ̤òÀ©¸Â¤·¤Ê¤¬¤éº£¡¡¿©Á°100°Ê²¼ ¿©¸å¡Ê+±¿Æ°) 120¡Á135 ¤Ç¥³¥ó¥È¥í¡¼¥ë¤·¤Æ¤ª¤ê¤Þ¤¹¡£°ø¤ß¤ËÌô¤Ï°ìÀÚ°û¤ó¤Ç¤Þ¤»¤ó¡£ÀèÀ¸¤¬À֥磻¥ó¤È¥Ê¥Ã¥Ä¤Çenjoy¤µ¤ì¤Æ¤¤¤ë¤ÈÃΤꡢ»ä¤â¤³¤³£±½µ´ÖËþµÊ¤·¤¿À¸³è¤òÁ÷¤ì¤ëÍͤˤʤê¤Þ¤·¤¿¡£ËÜÅöÁÇÀ²¤é¤·¤¤¤Ç¤¹¡£´¶¼Õ¤Î°ÕÌ£¤â´Þ¤á¤ÆÆüËܤ˵¢¤Ã¤¿¤é¨ËܤòÇã¤Ã¤Æ¡¢±ÉÍܻΤοͤ˴«¤á¤Æ¤ß¤è¤¦¤È»×¤Ã¤Æ¤Þ¤¹¡£¡¡
¿©¸å£²»þ´Ö¤Î½ÅÍ×À¤ò»ä¤ÎôÅö°å¤ØÁêÃ̤·¤¿»ö¤¬¤¢¤ê¡¢¤½¤Î»þ¤Ï¶²¤é¤¯È¯¾É½é´ü¤Ç¤¢¤ë¤¿¤á¤« ¼è¤ê´º¤¨¤ºµ¯¾²»þ¤Î¤ß¬Äꤹ¤ëÍͤ˻ؼ¨¤ò¼õ¤±¤Æ¤Þ¤¹¤¬¡¢¸Ä¿ÍŪ¤Ë¹¾ÉôÀèÀ¸¤Î°Õ¸«¤Ë²ÄÌ鯱°Õ¤·¤Æ¤ª¤ê¡¢ÅÔÅÙ¬Äꤷ¤¿¤¤¤Î¤Ç¤¹¤¬¡¢»ÄǰÆã »ý¤Ã¤Æ¤¤¤ë¥Á¥Ã¥×¿ô¤¬Â¤é¤Ê¤¯¤Ê¤ë¤Î¤Ç¤¢¤Þ¤ê¬Äê½ÐÍè¤Þ¤»¤ó¡£
ǯÎ𣳣°Âå¤È¤¤¤¦»ö¤â¤¢¤ê¡¢À§ÈóÀèÀ¸¤Î°Õ¸«¤òĺÂפ·¤Æ¡¢¤³¤ì¤«¤é¤ÎŤ¤ÅüÇ¢À¸³è¤ò¾¯¤·¤Ç¤â·ò¹¯¿Í¤Ë¶á¤¤·Á¤Ç²á¤´¤»¤¿¤é¡¡¤È»×¤Ã¤Æ¤ª¤ê¤Þ¤¹¤Î¤Ç¡¢À§È󶦵¹¤·¤¯¤ª´ê¤¤Ãפ·¤Þ¤¹¡£
¼ã¼Ô£²·¿ÅüÇ¢¿Í | 2007.11.11(Æü) 23:51 | URL | ¡×
¼ã¼Ô£²·¿ÅüÇ¢¿Í¤µ¤ó¡£¥³¥á¥ó¥È¡¦¼ÁÌ䤢¤ê¤¬¤È¤¦¤´¤¶¤¤¤Þ¤¹¡£
¤Þ¤¿ ¡Ö¥«¥í¥ê¡¼À©¸Â¢ªÅü¼ÁÀ©¸Â¡×¤Ç¡¢ÁáÄ«¶õÊ¢»þ·ìÅüÃͤ¬£±£°£°£í£ç°Ê²¼¤È¥³¥ó¥È¥í¡¼¥ëÎɹ¥¤Ë¤Ê¤Ã¤¿¤È¤Î¤³¤È¡¢¤ª¤á¤Ç¤È¤¦¤´¤¶¤¤¤Þ¤¹¡£
¹¬¤¤·Ð¸ý·ìÅü¹ß²¼Ìô¤Ê¤ÉÆâÉþ¤·¤Æ¤ª¤é¤ì¤Þ¤»¤ó¤Î¤Ç¡¢°ÂÁ´¤ËÅü¼ÁÀ©¸Â¿©¤¬¼ÂÁ©¤Ç¤¤Þ¤¹¡£
¡Ö¡ º£¸åĹ´ü¤ËÏˤꡡ¡Ö¿Åü¼Á¿©»ö¡Ü¿©¸å±¿Æ°¡×¡¡¤Ç·ìÅüÃͤò¥³¥ó¥È¥í¡¼¥ë¤·Â³¤±¤ÆÎɤ¤¤â¤Î¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©
¿´ÇÛ»ö¤Ï¡¢¿©¸å¤Î±¿Æ°¤Î»þ´ÖÂÓ¤ò¶ËÎÏ£±¡Á1.5»þ´Ö¸å°ÊÆâ¤Ë³«»Ï¤¹¤ëÍÍ¡¡¿´³Ý¤±¤Æ¤Þ¤¹¤¬¡¢¿©¤Ù¤¿ÆâÍÆ¤Ë¤è¤Ã¤Æ¤Ï·ìÅüÃͤÎÊÑÆ°¤Î»ÅÊý¤¬»þ´ÖÂӤˤè¤Ã¤ÆÊѤï¤Ã¤Æ¤¤Þ¤¹¤·¡¢±¿Æ°¤ò¤· ·ë²ÌŪ¤Ë¿ôÃͤϲ¼¤¬¤Ã¤ÆÍè¤ë¤È¤Ï±¾¤¨¡¢¾¯¤Ê¤«¤é¤º°ìÄê¤Î»þ´Ö200 over¤È¤Ê¤Ã¤Æ¤¤¤ë²ÄǽÀ¤¬¹Í¤¨¤é¤ì¤Þ¤¹¡£
½Ö´ÖŪ¤Ë·ìÅüÃͤ¬¹â¤¤¤Î¤â¤ä¤Ï¤êÌäÂê¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©¡×
¡ã¿Åü¼Á¿©»ö¡Ü¿©¸å±¿Æ°¡ä¤Ç·ìÅüÃͤò¥³¥ó¥È¥í¡¼¥ë¤ò¤·Â³¤±¤Æ¤â£Ï£Ë¤Ç¤¹¡£
¥â¥Ç¥ë¤È¤·¤Æ¥Ô¥Þ¥¤¥ó¥Ç¥£¥¢¥ó¤¬¤¤¤Þ¤¹¡£Êƹñ¤Îµï½»¶è¤Ç¤¯¤é¤·¤Æ¤¤¤ë¥Ô¥Þ¥¤¥ó¥Ç¥£¥¢¥ó¤Ï¡ã¹âÅü¼Á¿©¡Ü±¿Æ°ÉÔ¡ä¤Ç¿Í¸ý¤Î£µ³ä¤¬ÅüǢɤǤ¹¡£
°ìÊý¡¢¥á¥¥·¥³¤Î¥Ô¥Þ¥¤¥ó¥Ç¥£¥¢¥ó¤Ï¡ã¹âÅü¼Á¿©¡Ü±¿Æ°¤¿¤Ã¤×¤ê¡ä¤ÇÅüǢɤϤۤȤó¤É¤¤¤Þ¤»¤ó¡£¡Ê£¹¡¥£²£·¡¢£²£¸¤Î¥Ö¥í¥°»²¾È¤·¤Æ¤¯¤À¤µ¤¤¤Í¡Ë
¤½¤ì¤«¤é¿©¸å·ìÅüÃÍ£±£¸£°£í£ç¡¿£ä£ì̤Ëþ¤¬ÌÜɸ¤Ç¤¹¡£¤³¤Î¿ôÃͤʤ顢·ì´É¤Î¹çÊ»¾É¤¬¤Û¤È¤ó¤ÉÀ¸¤¸¤Ê¤¤¤È¤µ¤ì¤Æ¤¤¤Þ¤¹¡£¡Ê¡ö¡öKumamoto Study¡¡·§ËÜÂç³Ø¡¡¡Ë
£±£¸£°£í£ç¡¿£ä£ì¤òͤ¨¤ë¹â·ìÅü¤¬»ý³¤¹¤ë¤Û¤É·ì´É¤Ë¤ÏÎɤ¯¤Ê¤¤¤Ç¤·¤ç¤¦¡£
¡Ö¢ ¤É¤¦¤·¤Æ¤â¿©¸å¤Î±¿Æ°¤¬½ÐÍè¤Ê¤¤¥±¡¼¥¹¤â½µ¤Ë£²,£³²óÄøÅÙ¤¢¤í¤¦¤«¤È»×¤¤¤Þ¤¹¡£
ÃæÄ¹´üŪ¤Ë¸«¤¿¾ì¹ç ¹¥¤Þ¤·¤¯¤Ê¤¤¤Î¤Ïʬ¤«¤ê¤Þ¤¹¤¬¡¢¹çÊ»¾É¤òµ¯¤³¤µ¤Ê¤¤°Ù¤Ë¤Ï¤É¤ÎÄøÅ٤Ǥ¢¤ì¤ÐÌäÂê¤Ê¤¤¤â¤Î¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©¡×
Kumamoto Study¤Ë¤è¤ì¤Ð¡¢¡ãHbA1c£¶¡¥£µ¡ó̤Ëþ¡¢¶õÊ¢»þ·ìÅüÃÍ£±£±£°£í£ç̤Ëþ¡¢¿©¸å·ìÅüÃÍ£±£¸£°£í£ç¡¿£ä£ì̤Ëþ¡ä¤Ê¤é¤Ð¹çÊ»¾É¤Î¿ÊŸ¤¬Á˻ߤǤ¤ë¤½¤¦¤Ç¤¹¡£
¡Ö£ °ìöÅüÇ¢¿Í¤Ë¤Ê¤Ã¤Æ¤·¤Þ¤Ã¤¿¾ì¹ç¡¢Âç¾®¥Ö¥É¥¦Åü¥¹¥Ñ¥¤¥¯¤Ïµ¯¤³¤ê³¤±¤ë¤â¤Î¤È¹Í¤¨¤ë¤Ù¤¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©¡Ê·ò¹¯¿Í¤Î¥¹¥Ñ¥¤¥¯¥ì¥Ù¥ë¤Ë¶á¤Å¤±¤ë²ÄǽÀ¤Ï¤Ê¤¤¤â¤Î¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡©¡Ë
¾¤ÎÊý¤Î¥Ö¥í¥°¤Ç¡¢´°¼£¤òÌܻؤ·¤Æ¤ª¤é¤ì¤ëÊý¤¬¤¤¤é¤Ã¤·¤ã¤Ã¤Æ¡¢½ÐÍè¤ì¤Ð»ä¤â´èÄ¥¤Ã¤Æ¤ß¤¿¤¤¤â¤Î¤Ç¤¹¤¬¡¢°å³ØÅª¤Ë¤ä¤Ï¤ê´°¼£¤Ï¸½¼ÂŪ¤Ç¤Ï¤Ê¤¤¤Î¤Ç¤·¤ç¤¦¤«¡©¡×
ÅüǢɤȿÇÃǤµ¤ì¤¿»þÅÀ¤Ç¡¢ç¹Â¡¤Î¦ÂºÙ˦¤Î£±¡Á£²³ä¤¬²óÉüÉÔǽ¤Î¥À¥á¡¼¥¸¤ò¼õ¤±¤Æ¤¤¤ë¤³¤È¤¬Â¿¤¤¤Ç¤¹¡£¤µ¤é¤Ë£²¡Á£³³ä¤ÎºÙ˦¤â¼å¤Ã¤Æ¤¤¤ë²ÄǽÀ¤¬¤¢¤ê¤Þ¤¹¡£
³°Éô¤«¤é¥¤¥ó¥¹¥ê¥óÃí¼Í¤òÂǤġ¢°¿¤¤¤Ï Åü¼ÁÀ©¸Â¿©¤Î¼ÂÁ©¤Ë¤è¤ê¡¢ç¹Â¡¤Î¦ÂºÙ˦¤¬µÙÍܤǤ¤Æ²óÉü¤¹¤ë¤³¤È¤Ï¤¢¤ê¤Þ¤¹¡£¡Ê£±£±¡¥£¹¥Ö¥í¥°»²¾È¤·¤Æ¤¯¤À¤µ¤¤¡Ë
½¾¤Ã¤Æ¡¢·ò¹¯¿Í¤Î¥ì¥Ù¥ë¤Ë¾¯¤·¶á¤Å¤¯¤³¤È¤Ï²Äǽ¤Ç¤¹¤¬¡¢´°Á´²óÉü¤Ï¤¢¤ê¤Þ¤»¤ó¡£
»ä¤â Åü¼ÁÀ©¸Â¿©¤ò³¤±¤ë¸Â¤ê¤Ï·ìÅü¥Ç¡¼¥¿¤ÏÀµ¾ï¿Í¤Ç¤¹¤¬¡¢Åü¼Á¤òÀݼ褹¤ì¤Ð¡¢Î㤨GI¤ÎÄ㤤¸¼ÊƤǤ⣲£°£°£í£ç¤òͤ¨¤Þ¤¹¡£
Îã³°¤È¤·¤Æ¡¢¥¤¥ó¥¹¥ê¥óʬÈçǽÎϤÏÊݤ¿¤ì¤Æ¤¤¤Æ¡¢¥¤¥ó¥¹¥ê¥óÄñ¹³À¤¬¼ç¡ÊÎ㤨¤ÐÈîËþ¤Î¤¿¤á¡Ë¤ÎÅüÇ¢¿Í¤Ï¡¢ÈîËþ¤¬²þÁ±¤¹¤ë¤³¤È¤ÇÀµ¾ï¿Í¤ËÌá¤ë¤³¤È¤Ï¤¢¤êÆÀ¤Þ¤¹¡£
¡ö¡öKumamoto Study
Shichiri M, Kishikawa H, Ohkubo Y, Wake N: Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23 Suppl 2:B21-29, 2000
¹¾Éô¹¯Æó
¥Æ¡¼¥Þ:
ÅüǢɠ-
¥¸¥ã¥ó¥ë:
¥Ø¥ë¥¹¡¦¥À¥¤¥¨¥Ã¥È

